0 followers
Step Pharma is developing a novel class of oral nucleotide synthesis inhibitors specifically targeting cytidine triphosphate synthase 1 (CTPS1) to induce selective modulation of T and B cell populations.
Industries
Headquarters
Employees
Links
View full screen
Andrew Parker
View all
9 members
6 members
3 members
2 members
DEINOVE
1 follower
Coave Therapeutics
2 followers
GENFIT
Cartesian Therapeutics
Tempus Labs
12 followers
Explore more companies